PharmaBlock Group
Celine Chen has a range of work experience in marketing and communications. Celine currently holds the position of Senior Director of Business and Marketing Strategy at PharmaBlock Group, where they have been since March 2022. Prior to this role, they held the position of Director of Business Strategy, Marketing, and Communication at PharmaBlock from January 2017 to May 2022. Before joining PharmaBlock, Celine worked as an Associate Director of Marketing and Public Relations from March 2016 to January 2017. Celine also has experience in public relations and client management, having worked as a Manager at Burson-Marsteller from February 2015 to February 2016. Additionally, they have experience as an Account Executive at TransComm Group from February 2014 to January 2015 and as a Marketing Specialist at Sunshine Apparel Inc. from June 2012 to January 2014. Celine started their career as a Teaching Assistant at the University of Kentucky from August 2009 to May 2011.
Celine Chen earned a Master's Degree in Communication from the University of Kentucky between 2009 and 2011. Celine also obtained additional certifications, including "Green Economy and Trade" from the United Nations Institute for Training and Research in 2023, "An Introduction to Marketing" from the Wharton School, University of Pennsylvania via Coursera in 2014, and "Foundations of Business Strategy" from the University of Virginia via Coursera in 2013.
This person is not in any teams
This person is not in any offices
PharmaBlock Group
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products & services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building blocks (BBs) collection, supplying from discovery, to development & commercial; development & manufacturing of RSMs, intermediates & APIs for drug development & commercial. Officially operated in 2008, PharmaBlock has rapidly gained recognition for its outstanding capabilities in the design, synthesis, & supply of novel BBs. It has generated a large and unique collection of high-quality and diverse BBs, which are increasingly adopted by drug hunters to enrich the structure options, improve compound quality, expand patent space and eventually accelerate drug discovery projects. Inspired by the BBs, it has established a powerful drug discovery platform for medicinal chemists to quickly identify hit/lead. The platform includes a set of efficient tools, including but not limited to FBDD, DELT, & Virtual Screening. Following the new molecules advancing from discovery to development, and into the market, the company is committed to a more comprehensive & long-term service to valued customers. In addition to strengthening process R&D capabilities & mfg. capacity to secure the sustainable supply of BBs, the company is providing CDMO solutions of RSMs, key intermediates & APIs. To further realize safe, efficient and green process & mfg., it has developed an advanced chemistry & engineering technology platform, featuring flow chemistry, micropacked bed hydrogenation, catalysis, crystallization, solid state chemistry etc. Over the past years, PharmaBlock has partnered with almost all the top pharmaceutical companies, and hundreds of small to medium-sized biotechs around the world. Our ever changing mission is to support clients to accelerate drug discovery & development, and move the new molecule to commercial in full speed.